An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)

摘要

Objective: To describe the implementation and results of a proactive patient outreach project to offer selfadministered, depot medroxyprogesterone (DMPA) subcutaneous (SC) to interested patients at a California safety-net clinic following expanded state Medicaid coverage.